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Abstract
Objective Posterior circulation ischemic stroke (PCiS) constitutes 20–30% of ischemic stroke cases. Detailed information 
about differences between PCiS and anterior circulation ischemic stroke (ACiS) remains scarce. Such information might 
guide clinical decision making and prevention strategies. We studied risk factors and ischemic stroke subtypes in PCiS vs. 
ACiS and lesion location on magnetic resonance imaging (MRI) in PCiS.
Methods Out of 3,301 MRIs from 12 sites in the National Institute of Neurological Disorders and Stroke (NINDS) Stroke 
Genetics Network (SiGN), we included 2,381 cases with acute DWI lesions. The definition of ACiS or PCiS was based on 
lesion location. We compared the groups using Chi-squared and logistic regression.
Results PCiS occurred in 718 (30%) patients and ACiS in 1663 (70%). Diabetes and male sex were more common in PCiS 
vs. ACiS (diabetes 27% vs. 23%, p < 0.05; male sex 68% vs. 58%, p < 0.001). Both were independently associated with PCiS 
(diabetes, OR = 1.29; 95% CI 1.04–1.61; male sex, OR = 1.46; 95% CI 1.21–1.78). ACiS more commonly had large artery 
atherosclerosis (25% vs. 20%, p < 0.01) and cardioembolic mechanisms (17% vs. 11%, p < 0.001) compared to PCiS. Small 
artery occlusion was more common in PCiS vs. ACiS (20% vs. 14%, p < 0.001). Small artery occlusion accounted for 47% 
of solitary brainstem infarctions.
Conclusion Ischemic stroke subtypes differ between the two phenotypes. Diabetes and male sex have a stronger association 
with PCiS than ACiS. Definitive MRI-based PCiS diagnosis aids etiological investigation and contributes additional insights 
into specific risk factors and mechanisms of injury in PCiS.
Keywords Stroke · Posterior circulation brain infarction · Risk factors · Magnetic resonance imaging · Phenotyping
Introduction
Posterior circulation ischemic stroke (PCiS) refers to infarc-
tion in any brain structure supplied by the vertebrobasilar 
arterial system. The reported prevalence of PCiS ranges 
between 20 and 30% in most hospital-based cohorts [1–3]. 
To a large extent, PCiS and anterior circulation ischemic 
stroke (ACiS) share vascular risk factors and stroke mecha-
nisms [1, 4]. PCiS has been reported to occur more com-
monly than ACiS in young patients in whom cervical artery 
dissection is more frequent [5] and in patients with MELAS 
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and Fabry’s disease [6]. Previous studies comparing PCiS 
and ACiS suffer from heterogeneous sample sizes, diag-
nostic criteria, imaging methods, and subtype classifica-
tion. The reported prevalence of conventional vascular risk 
factors such as hypertension, diabetes mellitus, and atrial 
fibrillation in PCiS has varied widely [2, 7]. The prevalence 
of ischemic stroke subtypes in PCiS also varies in previous 
reports [1, 2, 8]. An accurate PCiS diagnosis may be difficult 
to make without appropriate imaging, hence prevalence data 
based on clinical diagnosis alone or in combination with 
computer tomography may be unreliable. Diagnosis of PCiS 
has become easier with the increasing availability of MRI, 
but there are still few large series of MRI-verified PCiS on 
which prevalence and etiology data can be based. Few stud-
ies have correlated DWI lesion distribution in the posterior 
circulation with ischemic stroke subtype. Previous, primarily 
small, studies have specifically studied infratentorial lesions 
or the brainstem alone [9]. Here, we describe a large sample 
of PCiS cases systematically ascertained through radiologi-
cal assessment of the acute lesions on DWI MRI in associa-
tion with baseline characteristics, vascular risk factors, and 
stroke mechanisms compared to ACiS in the same study.
Methods
Setting
We reviewed all ischemic stroke cases in the neuroimag-
ing repository of the MRI-GENetics Interface Exploration 
(MRI-GENIE) collaboration [10]. Data were contributed by 
12 of the original National Institute of Neurological Disor-
ders and Stroke Genetics Network (NINDS–SiGN) study 
sites [11]. Previous publications provide detailed descrip-
tions of the NINDS-SiGN and MRI-GENIE studies, as well 
as collection periods and inclusion criteria for each site [10, 
12].
Study population
Participating sites included five US. sites and seven Euro-
pean sites. Ten sites had hospital-based identification and 
two sites contributed population-based data. One center con-
tributed only data on young stroke patients, aged 15–49, and 
one center included only patients under the age of 70. Three 
sites included only first-ever ischemic stroke cases (n = 562) 
(Supplementary Table 1 details baseline data for included 
patients per site).
Clinical phenotyping
Each site collected demographic and vascular risk factor data 
at the time of enrollment. Clinical phenotype data included 
age, sex, hypertension, diabetes mellitus, atrial fibrillation, 
smoking status, and ischemic stroke mechanism. Ten sites 
contributed data on stroke severity according to the National 
Institute of Health Stroke Scale (NIHSS). MRI lesion loca-
tion findings (left/right hemisphere, cerebellum, brainstem, 
multiple) as reported by each center’s local radiology depart-
ment were submitted to the central image repository.
MRI evaluation
MRI scans were transferred to the MRI-GENIE neuro-
imaging repository in DICOM format and were available 
for review through a secure XNAT viewer [10]. Two sen-
ior neuroradiologists (J.W., M.D.), blinded to the original 
evaluation regarding the presence of DWI lesions, vascular 
territory and location, centrally reviewed all MRI images. 
We excluded cases for poor image quality, lack of DWI 
sequences, absence of visible acute ischemic lesion on DWI, 
and the presence of acute ischemic lesions in both vascular 
territories. We grouped patients according to DWI lesion 
location: We defined lesion(s) in the territory of the poste-
rior cerebral artery (PCA) and its penetrating arteries and in 
the territories of the vertebral (VA) or basilar arteries (BA) 
as PCiS. Because we based the stroke phenotypes on DWI 
lesion location, PCiS was considered present even when a 
fetal PCA was identified ipsilateral to the acute ischemic 
lesion. Lesions in the middle cerebral artery (MCA), anterior 
cerebral artery (ACA), or anterior choroidal artery (ACoA) 
vascular territories were defined as ACiS. The reviewers also 
recorded the side of lesion (left/right), cerebellar or brain-
stem location in infratentorial lesions, cortical/subcortical 
location for supratentorial lesions, and whether lesions were 
single or multiple. The reviewers assessed vessel patency 
and evidence of vessel occlusion related to lesion location 
was assessed in the major intracerebral arteries: the VA, 
the BA, the PCA, MCA, and ACA. When neck MRA was 
available, the extracranial portion of the VA and the internal 
carotid arteries (ICA) were assessed regarding the presence 
of occlusion or stenosis. Reviewers did not specify whether 
occlusions in the VA were intracranial or extracranial. We 
did not assess the infratentorial branches of the VA and BA 
for presence of occlusion.
Stroke mechanisms
We classified all patients according to the web-based Causa-
tive Classification of Stroke system (CCS) [13, 14]. Previous 
publications provide details of the specifics of CCS subtyp-
ing within SiGN [12]. Certified physician raters at each GRC 
adjudicated data on clinical histories and diagnostic testing 
and fed the information into the web-based CCS system. 
We used five major CCS subtypes for ischemic stroke; car-
dioembolic major (CE), large artery atherosclerosis (LAA), 
651Journal of Neurology (2020) 267:649–658 
1 3
small artery occlusion (SAO), undetermined (UNDETER), 
and other (OTHER). A subset of sites also submitted clas-
sification of stroke subtype according to Trial of ORG 10172 
in Acute Stroke Treatment (TOAST) [15].
Analysis
We performed univariable analyses of baseline data for 
each of the two groups and between groups using the 
Mann–Whitney test for non-parametric variables and the χ2 
test for categorical variables. Missing data points and risk 
factor variables recorded as Unknown did not exceed 3% 
for any single variable, except for NIHSS (22%). Missing 
data points were not included in any analyses. All vascular 
risk factors, including current smoking, were tested in the 
univariable analysis. A logistic regression model was cre-
ated for comparison of risk factors between groups. Vari-
ables that were not significant in the univariable analysis 
were removed from the model in the multivariable analysis. 
Statistical analyses were performed using SPSS 23.0 and 
SPSS 25.0.
Ethics
This study and its constituent substudies were conducted 
in accordance with the Helsinki Declaration as revised in 
2013. The MRI-GENIE study has been approved by the 
institutional review board at Massachusetts’ General Hos-
pital, Boston, MA. All participants provided informed con-
sent either directly or through surrogate authorization at the 
time of enrollment at the original sites.
Ethical approval
MRI-GENIE IRB number: #: 2001P001186.
Results
At the time of evaluation, the MRI-GENIE database con-
tained MRIs of 3,301 ischemic stroke cases. After exclu-
sion for technical or quality reasons, a total of 2,469 cases 
with DWI positive lesions on MRI remained. After exclu-
sion of patients with acute lesions in both vascular terri-
tories (n = 87) or without a decisive allocation of vascular 
territory (n = 1), 2,381 cases with acute ischemic lesions on 
DWI remained for analysis. The demographic and risk factor 
characteristics of the excluded patients with ischemic lesions 
in more than one vascular territory (n = 87) are available 
in Supplementary Table 2. Thirteen patients with posterior 
lesions and ipsilateral fetal-type PCA were as PCiS. Mag-
netic resonance angiography (MRA) was available for 1,360 
patients. Time from stroke onset to scan was recorded in 
89% of cases. A majority (58%) was scanned within 48 h 
and 86% had been scanned within 14 days. Median time to 
scan was 1 day.
Baseline characteristics and risk factors
Baseline characteristics, vascular risk factor prevalence and 
association with respective stroke phenotype for all patients 
are shown in Table 1.
Thirty percent of patients had ischemic lesions in the VB/
BA/PCA territories and 70% had lesions in the MCA/ACA 
territories on MRI-DWI. Patients with PCiS were younger 
than those with ACiS. The proportion of men in the PCiS 
group was significantly higher than in ACiS. In men with 
ischemic stroke, 32% had PCiS vs. 24% of women with 
ischemic stroke. Male sex was independently associated with 
PCiS compared with ACiS.
Diabetes mellitus was more common in PCiS than in 
ACiS and remained independently associated with PCiS 
Table 1  Vascular risk factor 
association in ACiS vs. PCiS
ACiS anterior circulation ischemic stroke, PCiS posterior circulation ischemic stroke, CAD coronary artery 
disease, NIHSS National Institute of Health Stroke Scale, IQR interquartile range
a Logistic regression model adjusting for age, sex, diabetes mellitus, atrial fibrillation, and current smoking
b Hypertension and coronary artery disease were not included in the multivariable analysis
ACiS PCiS Univariable Multivariablea
n = 1 663 (%) n = 718 (%) OR 95% CI OR 95% CI
Age (median) 66 63 0.99 0.98–0.99 0.99 0.98–1.00
Male 967 (58) 487 (68) 1.52 1.26–1.82 1.46 1.21–1.78
Hypertensionb 1 096 (66) 451 (64) 0.90 0.75–1.08 – –
Diabetes mellitus 373 (23) 190 (27) 1.27 1.03–1.55 1.26 1.02–1.56
Atrial fibrillation 261 (16) 78 (11) 0.64 0.48–0.83 0.70 0.52–0.93
CADb 298 (18) 115 (16) 0.88 0.69–1.11 – –
Current smoking 462 (28) 154 (21) 0.71 0.58–0.87 0.63 0.51–0.79
NIHSS (IQR) 4 (2–7) 3 (1–5) – – – –
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after adjusting age, sex, atrial fibrillation, and smoking 
status. Atrial fibrillation was less common in patients with 
PCiS than ACiS. Women with PCiS were significantly 
more likely to have atrial fibrillation than men (15% vs. 9%, 
p < 0.05). (Supplementary Table 3 details prevalence of risk 
factors and CCS in PCiS according to sex).
DWI lesion topography in PCiS
Among 718 PCiS patients, 197 (27%) had lesions limited 
to the PCA territory. Cerebellar lesions without concur-
rent brainstem or supratentorial lesions were found in 158 
(22%) patients. Isolated brainstem lesions without cerebellar 
or supratentorial posterior lesions occurred in 241 patients 
(33%), and were almost exclusively solitary. Multiple lesions 
limited to the brainstem were rare and occurred in only 28 
patients (1%). Infratentorial lesions without evidence of 
supratentorial lesions were present in 424 (59%) cases. In 
97 (14%) patients, we found both infratentorial lesions and 
lesions in the PCA territory.
Vessel occlusion
MRA sequences were available for 1,360 cases (ACiS, 
n = 950; PCiS, n = 410). The proportion of MRA investiga-
tions did not differ between the groups (57%). Vessel occlu-
sion determined to be related to the site of lesion detected 
in 273 (28%) patients with ACiS vs. 159 (39%) with PCiS. 
Sixty-five (55%) patients among 119 patients with isolated 
PCA had a visible artery occlusion related to site of lesion. 
The most common sites were the ipsilateral P1–P3 segments.
Ischemic stroke subtypes according to CCS
Ischemic stroke subtype data according to CCS were avail-
able for all patients. The proportion of patients assigned with 
the CCS subtype UNDETER was similar in both groups 
(ACiS 38%, PCiS 39%). The subtype OTHER was assigned 
in a small number of patients in both groups, with a sig-
nificantly higher proportion in PCiS than in ACiS (10% vs. 
6%, p < 0.01). The distribution of specific subtypes (CE, 
LAA and SAO) differed significantly between ACiS and 
PCiS (Fig. 1). The subtypes SAO and LAA were equally 
common (20%) in PCiS, while LAA was the most common 
(25%) subtype in ACiS. We studied ischemic stroke sub-
type in relation to DWI lesion location in PCiS (Fig. 2). The 
most common CCS subtype was UNDETER for all locations 
except brainstem location. Single, isolated brainstem lesions 
were attributed to SAO in 47% of the cases and multiple 
lesions limited to the brainstem were attributed to LAA in 
25%. Solitary brainstem lesions were highly predictive for 
the SAO subtype (Table 2).
Large artery atherosclerosis was the second most com-
mon stroke subtype in exclusively supratentorial (23%) and 
isolated cerebellar infarctions (18%) followed by cardioem-
bolism (15%, respectively). In patients with both cerebellar 
and/or brainstem and supratentorial lesions, LAA was the 
dominant subtype. Among PCiS patients investigated with 
MRA, the proportion of strokes assigned to the CCS subtype 
SAO was significantly lower than in PCiS patients not inves-
tigated with MRA (16% vs. 24%). Conversely, the propor-
tion of patients classified as LAA was higher (23% vs. 16%) 
when angiography had been part of the initial assessment. 
There was no corresponding shift in CCS type assignment 
in the ACiS group.
Fig. 1  Proportion of ischemic 
stroke subtypes in ACiS vs. 
PCiS. ACiS anterior circulation 
ischemic stroke, PCiS posterior 
circulation ischemic stroke, 
CE cardioembolism, LAA large 
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Discussion
In this large sample of MRI-DWI phenotyped cases, we 
compared anterior and posterior circulation strokes regard-
ing risk factor association and ischemic stroke subtypes. 
We also correlated ischemic stroke subtypes according 
to CCS to lesion location in PCiS. We found that PCiS 
occurred in 30% of the patients, which is in the upper 
range compared with previously published studies in 
which PCiS prevalence has been reported between 15 
and 30% depending on stroke subtype classification and 
diagnostic imaging methods [7, 16, 17]. The accuracy 
of ischemic stroke subtyping and subsequent risk factor 
assessment has implications in patient management. We 
believe that this large set of MRI-DWI-verified posterior 
circulation ischemic stroke cases contributes reliable data 
regarding risk factor characteristics and stroke mecha-
nisms for this patient group.
Vascular risk factors
Demographic and risk factor prevalences differed between 
the two stroke phenotypes. PCiS patients were more often 
male, of younger age, and more frequently diabetic. ACiS 
patients more frequently had atrial fibrillation and were 
current smokers. Younger age in PCiS has been reported 
previously [1, 18–20]. Previous findings regarding hyper-
tension in PCiS vs. ACiS have been divergent: It has been 
reported as a risk factor for PCiS in some studies [20, 21], 
while in others, this finding has not been corroborated [1, 
2]. Known risk factor data in PCiS are based on a hetero-
geneous set of studies in which the diagnostic certainty 
varies due to different modes of investigation and diag-
nostic criteria between studies and often a low number of 
PCiS cases.
Fig. 2  DWI lesion location 
and ischemic stroke subtype in 
PCiS. PCiS posterior circulation 
ischemic stroke, CE cardioem-
bolism, LAA large artery ath-













Brainstem only                       
n = 241
Cerebellum only                    
n = 158




CE LAA SAO UNDETERMINED OTHER% within lesion location
Table 2  Lesion location and association with CCS subtype
Binary logistic regression. CCS subtype vs. all other subtypes for specified anatomical location
SAO small artery occlusion, LAA larger artery atherosclerosis, CE cardioembolism
*Denotes p < 0.01; regarded as significant to correct for multiple testing
SAO (95% CI) LAA (95% CI) CE (95% CI) Undetermined (95% CI) Other (95% CI)
Brainstem only OR 9.99 (6.50–15.30)* OR 0.59 (0.30–0.89) OR 0.31 (0.16–0.58)* OR 0.59 (0.43–0.82) OR 0.38 (0.20–0.71)
Cerebellum only OR 0.06 (0.02–0.19)* OR 0.90 (0.57–1.41) OR 1.55 (0.93–2.59) OR 1.21 (0.85–1.73) OR 3.99 (2.40–6.63)*
PCA only OR 0.62 (0.40–0.97) OR 1.31 (0.88–1.96) OR 1.62 (1.00–2.62) OR 1.17 (0.84–1.63) OR 0.41 (0.21–0.82)
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Specific risk factors in PCiS
In multivariable analyses, diabetes mellitus was indepen-
dently associated with PCiS. This is in line with previous 
reports of an increased prevalence of PCiS vs. ACiS in dia-
betic patients [1, 19, 22]. Diabetes is a known risk factor for 
ischemic stroke [23, 24] and is associated with both microan-
giopathy and macroangiopathy through complex metabolic 
pathways. Autopsy studies have revealed a higher burden of 
infratentorial ischemic lesions in diabetic patients [25, 26]. 
More recently, image-based studies have reported a signifi-
cant difference in lesion distribution between diabetic and 
non-diabetic patients, with a larger proportion of infarctions 
in the VB system in diabetic patients [27, 28]. The reasons 
for the higher prevalence of PCiS in diabetic patients remain 
unclear with unknown mechanisms for greater susceptibility 
of the vertebrobasilar arteries to diabetes-related injury and 
atherogenesis. The prevalence of diabetes mellitus among 
PCiS patients with the ischemic stroke subtypes SAO or 
LAA was 69% vs. 53% in ACiS patients with the same CCS 
subtypes. This may indicate that there are mechanisms of 
diabetic injury specifically affecting the vertebrobasilar 
arteries in ways that remain to be elucidated. A recent study 
aiming to establish causative links between type 2 diabetes 
(T2D) and specific ischemic stroke subtypes showed a firm 
association for T2D with large artery stroke, but not with 
small artery stroke [29].
The complex influence of biological sex on ischemic 
stroke risk was beyond the scope of our current study. How-
ever, male sex as risk factor for PCiS vs. ACiS has been 
reported previously [19–21]. A male preponderance in 
PCiS has been observed in both children [30] and young 
adults [5]. There are studies indicating sex differences in the 
autoregulatory capacity of the basilar artery in young teens 
[31] and a significantly lower cerebrovascular reactivity to 
l-arginine in the posterior circulation in adult males [32].
Lesion location and CCS subtype
We explored the lesion location and CCS subtype sepa-
rately for the PCA territory, the cerebellum and the brain-
stem. In isolated brainstem lesions, the SAO subtype pre-
dominated. Lesions in the PCA territory and cerebellum 
were most often related to LAA or CE. This is in keep-
ing with previous reports [16, 33, 34]. In our study, SAO 
and LAA were equally common in PCiS overall, but on 
analysis of the relationship between location and ischemic 
stroke subtype, we found that exclusive, solitary brainstem 
lesions are heavily associated with and highly predictive of 
small artery occlusion. However, small brainstem lesions 
may be caused by occlusions in branch arteries, or severe 
stenosis of the basilar artery and may be routinely misclas-
sified as small artery occlusion, unless vascular imaging 
of the vertebrobasilar tree is performed. This maybe one 
explanation for the difference in the proportion of patients 
classified as SAO in PCiS patients with and without MRA 
in our analysis. Comparisons between this study and other 
registries and studies on PCiS may be unreliable due to the 
use of different classification systems for stroke subtypes 
across studies [16, 21, 33, 34]. Agreement between CCS 
and TOAST has been shown to be moderate and differs 
by subtype [35]. The prevalence of cardioembolic stroke 
in one study [21] was 24%, while 11% of PCiS in our 
study was classified as CE. In keeping with several previ-
ous studies [7, 22, 36], cardioembolism was significantly 
more common in ACiS vs. PCiS. The overall prevalence 
of atrial fibrillation in this study (14%) is similar to that in 
other large hospital-based ischemic stroke cohorts [37] for 
the same age group. The high (39%) proportion of visible 
vessel occlusions in PCiS on MRA indicates that a large 
proportion of PCiS are embolic, especially distal lesions 
affecting the cerebellum and the PCA territory.
Limitations
This study has several limitations. Not all patients pre-
senting with clinical stroke and subsequently enrolled at 
each study center had MRI imaging. The inclusion in our 
study of only cases with DWI lesions may have led to 
selection bias in terms of stroke severity, if patients with 
very severe stroke were not considered for MRI investiga-
tions. It may also have resulted in the exclusion of genuine 
ischemic stroke cases, since negative DWI in the acute 
stage occurs, particularly with smaller lesions and may dif-
fer between anterior and posterior locations [38]. Negative 
DWI is more common in PCiS than ACiS, in part due to 
the smaller volume of perfused brain parenchyma in the 
posterior fossa, but also because image artifacts are more 
common in this location than in the anterior circulation 
[39].
A potential limitation is the exclusion of 87 patients 
with acute ischemic lesions in more than one vascular ter-
ritory. Since cardiac embolism as a causative mechanism 
is often overrepresented in patients with acute lesions 
in multiple vascular territories, exclusion of this group 
(n = 87) from our analyses could potentially have led to 
a false high proportion of other causative mechanisms 
or risk factors, such as diabetes, in the PCiS group. To 
explore this potential bias, we performed a sensitivity 
analysis in which the 87 patients intended for exclusion 
were added to the PCiS group and compared to the ACiS 
group using the same statistical methods as for the main 
analysis. The results of the sensitivity analysis did not 
differ significantly from the results of the main analyses 
presented in Table 1.
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Strengths
The strict stroke phenotyping and definitive PCiS diagno-
sis achieved by verification of DWI positive lesions, and 
the high number of included cases are the major strengths 
of our study. Enrollment at the individual study sites was 
based on all ischemic stroke, regardless of vascular terri-
tory involved, and therefore the comparison between ACiS 
and PCiS in our study may be generalizable to ischemic 
stroke populations in secondary and tertiary stroke centers.
Conclusions
PCiS is a heterogeneous stroke phenotype with distinct 
features related to vascular supply, lesion location, and 
associated ischemic stroke subtype. The proportion of ves-
sel occlusion observed in PCiS is high. Visualization of 
the VB vascular tree and MRI lesion site(s) and distribu-
tion may aid in determining likely clinical stroke subtype 
in PCiS, which may influence selection of treatment of 
risk factors and secondary prevention strategies. Our study 
indicates an increased risk of PCiS vs. ACiS in diabetic 
patients and in males after adjusting for other conventional 
stroke risk factors. Genetically determined molecular path-
ways may specifically influence pathogenic processes in 
the vertebrobasilar arteries. MRI-based phenotyping of 
PCiS vs. ACiS may contribute valuable insights into spe-
cific risk factor profiles and mechanisms of injury in PCiS.
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